What does raloxifene treat?

Raloxifene, also known by its brand name, Evista, is approved by the U.S. Food and Drug Administration (FDA) for two conditions: osteoporosis and breast cancer. Osteoporosis is a condition in which bones get weak, raising the risk of serious fractures. Evista may be used by postmenopausal women to prevent or treat osteoporosis.

Evista may also be used by women who are at an especially high risk of invasive breast cancer, to reduce their risk of that disease. Women who already have osteoporosis may also decide to take raloxifene to reduce their risk of breast cancer.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.